Free Trial
NYSE:NEUE

NeueHealth (NEUE) Stock Price, News & Analysis

NeueHealth logo
$5.11
-0.03 (-0.58%)
(As of 11/1/2024 ET)

About NeueHealth Stock (NYSE:NEUE)

Key Stats

Today's Range
$5.02
$5.20
50-Day Range
$4.86
$5.96
52-Week Range
$4.69
$16.59
Volume
6,854 shs
Average Volume
18,691 shs
Market Capitalization
$42.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Hold

Company Overview

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

NeueHealth Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
48th Percentile Overall Score

NEUE MarketRank™: 

NeueHealth scored higher than 48% of companies evaluated by MarketBeat, and ranked 627th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    NeueHealth has received no research coverage in the past 90 days.

  • Read more about NeueHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeueHealth is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeueHealth is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about NeueHealth's valuation and earnings.
  • Percentage of Shares Shorted

    1.15% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in NeueHealth has recently decreased by 1.78%, indicating that investor sentiment is improving.
  • Dividend Yield

    NeueHealth does not currently pay a dividend.

  • Dividend Growth

    NeueHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.15% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in NeueHealth has recently decreased by 1.78%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NeueHealth this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $451.00 in company stock.

  • Percentage Held by Insiders

    64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about NeueHealth's insider trading history.
Receive NEUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter.

NEUE Stock News Headlines

NeueHealth (NEUE) Scheduled to Post Quarterly Earnings on Thursday
Miami-Dade company buys out health firm in $102 million deal
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
NeueHealth Reports Second Quarter 2024 Results
NeueHealth, Inc. (NEUE)
See More Headlines

NEUE Stock Analysis - Frequently Asked Questions

NeueHealth's stock was trading at $6.53 on January 1st, 2024. Since then, NEUE shares have decreased by 21.7% and is now trading at $5.11.
View the best growth stocks for 2024 here
.

NeueHealth, Inc. (NYSE:NEUE) released its quarterly earnings data on Wednesday, August, 7th. The company reported ($6.42) earnings per share for the quarter. The firm had revenue of $225.99 million for the quarter. NeueHealth had a negative trailing twelve-month return on equity of 5.90% and a negative net margin of 90.79%.

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT).

Company Calendar

Last Earnings
8/07/2024
Today
11/02/2024
Next Earnings (Confirmed)
11/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
N/A
Fax
N/A
Employees
1,252
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+56.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-1,151,450,000.00
Pretax Margin
-55.84%

Debt

Sales & Book Value

Annual Sales
$1.03 billion
Cash Flow
$63.88 per share
Book Value
($158.35) per share

Miscellaneous

Free Float
2,956,000
Market Cap
$42.31 million
Optionable
N/A
Beta
0.78
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:NEUE) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners